Differential substrate use in EGF‐ and oncogenic KRAS‐stimulated human mammary epithelial cells
Mark A. Keibler(Alnylam Pharmaceuticals (United States)), Gregory Stephanopoulos(Massachusetts Institute of Technology)
Cited by 6
Related Papers
Engineering Cell Shape and Function
|Science|1994|1.4k
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
|Nature Genetics|2011|1.1k
A roadmap for interpreting 13C metabolite labeling patterns from cells
|Current Opinion in Biotechnology|2015|652
Hepatic Insulin Resistance Is Sufficient to Produce Dyslipidemia and Susceptibility to Atherosclerosis
|Cell Metabolism|2008|460
Engineering <i>Yarrowia lipolytica</i> as a platform for synthesis of drop-in transportation fuels and oleochemicals
|Proceedings of the National Academy of Sciences|2016|446